Lamifiban (Ro-44-9883; Ro 44-9883) is a novel and potent glycoprotein IIb/IIIa antagonist and a platelet aggregation inhibitor. Lamifiban prevents platelet loss during experimental cardiopulmonary bypass. Lamifiban inhibits platelet aggregation and thrombus formation by preventing the binding of fibrinogen to platelets.

纯度：≥98%

CAS：144412-49-7